Skip to content

Longitudinal Evaluation of a Fracture Liaison Service

Longitudinal Evaluation of a Fracture Liaison Service

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06847776
Acronym
FILFRA
Enrollment
500
Registered
2025-02-26
Start date
2025-01-02
Completion date
2030-01-02
Last updated
2025-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Keywords

osteoporosis, fractures, DXA, CT

Brief summary

The major objective of this study is to evaluated osteoporosis prevalence, both on computed tomography (CT) and dual x ray absorptiometry (DXA) in patients included in a fracture liaison service (FLS). The secondary objectives are to evaluate the prevalence of antiosteoporotic treatments indication, of new fractures or mortality; to identify the risk factor for osteoporosis; the study the treatment's observance; to identify the screening threshold to diagnose osteoporosis on CT.

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \>= 50 years * Bone fracture due to a fall

Exclusion criteria

* patient's opposition

Design outcomes

Primary

MeasureTime frame
Osteoporosis prevalence on DXA and CTduring the evaluation in the fracture liaison service FLS and evry year until 5 years

Secondary

MeasureTime frame
prevalnce of treatment for osteoporosisduring the evaluation in FLS and every year until 5 years
prevalence of new fractures at 1-3 and 5 yearsduring the evaluation in FLS and at 1, 3 and 5 years
identification of osteoporosis risk factorsat the inclusion in FLS
study of the correlation between FRAX score and lean massat the inclusion in FLS
study of the correlation dual x ray absorptiometry and computed tomography bone fragility evaluationat the inclusion in FLS
study of the correlation between FRAX score and DXAat the inclusion in FLS
study of the correlation between FRAX score and Trabecular bone score TBSat the inclusion in FLS
definition of the CT threshold for bone fragility in this population;at the inclusion in FLS

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026